S. Toupin , T. Pezel , P. Garot , K. Hamzi , T. Hovasse , T. Lefevre , B. Chevalier , T. Unterseeh , F. Sanguineti , S. Champagne , H. Benamer , A. Neylon , T. Ah-Sing , L. Hamzi , T. Goncalves , J.-G. Dillinger , P. Henry , V. Bousson , J. Garot
{"title":"Machine-Learning Score using Stress CMR and CCTA for prediction of cardiovascular events in patients with obstructive CAD","authors":"S. Toupin , T. Pezel , P. Garot , K. Hamzi , T. Hovasse , T. Lefevre , B. Chevalier , T. Unterseeh , F. Sanguineti , S. Champagne , H. Benamer , A. Neylon , T. Ah-Sing , L. Hamzi , T. Goncalves , J.-G. Dillinger , P. Henry , V. Bousson , J. Garot","doi":"10.1016/j.acvd.2023.10.016","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>In patients<span> with newly diagnosed coronary artery disease<span><span> (CAD), traditional prognostic risk assessment is based on a limited selection of clinical and imaging findings as coronary computed tomography angiography (CCTA) and stress </span>cardiovascular magnetic resonance (CMR). Machine learning (ML) methods can take into account a greater number and complexity of variables.</span></span></p></div><div><h3>Objective</h3><p>To investigate the feasibility and accuracy of ML using both stress CMR and CCTA data to predict major adverse cardiovascular events (MACE) in patients with newly diagnosed CAD, and compared its performance with existing clinical, CMR or CCTA scores.</p></div><div><h3>Method</h3><p>Between 2008–2020, consecutive symptomatic patients without known CAD referred for CCTA were screened. Patients with obstructive CAD (at least 1 ≥ 50% stenosis on CCTA) were further referred for stress CMR. Twenty clinical, 9 CCTA and 12 CMR parameters were evaluated. ML involved automated feature selection by LASSO, model building with a XGBoost algorithm (<span>Figure 1</span>A). The primary composite outcome was MACE defined by cardiovascular death or nonfatal myocardial infarction. The external validation cohort of the ML score was performed in another center (Lariboisiere Hospital).</p></div><div><h3>Results</h3><p>Of 2,210 patients who completed CMR, 2,038 (47% male, age 69<!--> <!-->±<!--> <span>12 years) completed the follow-up (median 6.8 [IQR 5.9–9.2] years), and 281 experienced a MACE (13.8%). The ML score exhibited a higher area under the curve compared with ESC risk score, QRISK3 score, Framingham risk score, SIS-core and CCTA or stress CMR data alone for prediction of MACE (ML-score: 0.85 vs. SIS-score: 0.71, stress CMR-score: 0.66, C-CMR-10-score: 0.62, QRISK3-score: 0.60, ESC-score: 0.55, FRS: 0.50, all </span><em>p</em> <!--><<!--> <!-->0.001, <span>Figure 1</span> B). The ML score also exhibited a good area under the curve in the external cohort (0.85).</p></div><div><h3>Conclusion</h3><p>The ML score including multimodality imaging data with both CCTA and stress CMR findings exhibited a higher prognostic value to predict MACE compared with any existing traditional method, traditional scores, and scores using only CCTA or CMR data.</p></div>","PeriodicalId":55472,"journal":{"name":"Archives of Cardiovascular Diseases","volume":"117 1","pages":"Pages S8-S9"},"PeriodicalIF":2.3000,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Cardiovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1875213623002115","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
In patients with newly diagnosed coronary artery disease (CAD), traditional prognostic risk assessment is based on a limited selection of clinical and imaging findings as coronary computed tomography angiography (CCTA) and stress cardiovascular magnetic resonance (CMR). Machine learning (ML) methods can take into account a greater number and complexity of variables.
Objective
To investigate the feasibility and accuracy of ML using both stress CMR and CCTA data to predict major adverse cardiovascular events (MACE) in patients with newly diagnosed CAD, and compared its performance with existing clinical, CMR or CCTA scores.
Method
Between 2008–2020, consecutive symptomatic patients without known CAD referred for CCTA were screened. Patients with obstructive CAD (at least 1 ≥ 50% stenosis on CCTA) were further referred for stress CMR. Twenty clinical, 9 CCTA and 12 CMR parameters were evaluated. ML involved automated feature selection by LASSO, model building with a XGBoost algorithm (Figure 1A). The primary composite outcome was MACE defined by cardiovascular death or nonfatal myocardial infarction. The external validation cohort of the ML score was performed in another center (Lariboisiere Hospital).
Results
Of 2,210 patients who completed CMR, 2,038 (47% male, age 69 ± 12 years) completed the follow-up (median 6.8 [IQR 5.9–9.2] years), and 281 experienced a MACE (13.8%). The ML score exhibited a higher area under the curve compared with ESC risk score, QRISK3 score, Framingham risk score, SIS-core and CCTA or stress CMR data alone for prediction of MACE (ML-score: 0.85 vs. SIS-score: 0.71, stress CMR-score: 0.66, C-CMR-10-score: 0.62, QRISK3-score: 0.60, ESC-score: 0.55, FRS: 0.50, all p < 0.001, Figure 1 B). The ML score also exhibited a good area under the curve in the external cohort (0.85).
Conclusion
The ML score including multimodality imaging data with both CCTA and stress CMR findings exhibited a higher prognostic value to predict MACE compared with any existing traditional method, traditional scores, and scores using only CCTA or CMR data.
期刊介绍:
The Journal publishes original peer-reviewed clinical and research articles, epidemiological studies, new methodological clinical approaches, review articles and editorials. Topics covered include coronary artery and valve diseases, interventional and pediatric cardiology, cardiovascular surgery, cardiomyopathy and heart failure, arrhythmias and stimulation, cardiovascular imaging, vascular medicine and hypertension, epidemiology and risk factors, and large multicenter studies. Archives of Cardiovascular Diseases also publishes abstracts of papers presented at the annual sessions of the Journées Européennes de la Société Française de Cardiologie and the guidelines edited by the French Society of Cardiology.